Romosuzumab and Low Sclerostin Levels Underlie CV Risk

Save

New research highlights potential safety concerns around women taking romosozumab, a new anti-osteoporosis drug available on the NHS.

Lupus During Pregnancy Carries Higher Maternal, Fetal Morbidity Risks

Save

Women with systemic lupus erythematosus (SLE) had higher risks for maternal and fetal morbidity compared to those without the chronic autoimmune disorder, according to a nationwide analysis of U.S. data.

Pericarditis Management

Save

On the final day of ACR 2023 State of the Art Conference, Dr. Paul Cremer reviewed pericarditis management. Dr. Cremer, a cardiologist at the Cleveland Clinic Foundation, reviewed the questions patients ask about pericarditis including why the disease develops, will it recur, how is it treated, and what will their treatment duration be. 

Treatment and Management of Neuropsychiatric Lupus

Save

On the first day of ACR State of the Art conference in Orlando, Florida, Dr. Michelle Petri reviewed the treatment and management of neuropsychiatric lupus. Dr. Petri, a lupus expert from Johns Hopkins Rheumatology, reviewed the latest clinical and animal model studies that offer hope in treatment and gave wide-ranging pearls on a variety of issues that can be faced in this disorder. 

ACR 2023 Convergence Brings Back the Poster Hall and 4 Day Meeting

Save

ACR Convergence 2023, the annual meeting of the American College of Rheumatology (ACR) and the world’s premier rheumatology experience, will be held Nov. 10 – 15 at the San Diego Convention Center in San Diego, CA.

ICYMI: What to do about pre-clinical RA?

Save

RheumNow Live’s 2023 conference led with this year’s hot topic of rheumatoid arthritis, especially what to do regarding pre-clinical RA. Dr. Kevin Deane started the discussion by mapping out a very complex course of RA, beginning with a person’s genetic and environmental risk factors. What are Dr. Deane’s recommendations for management of pre-RA patients?

PJP Prophylaxis Needed with Steroids and Rituximab

Save

Pneumocystis jirovecii pneumonia (PJP) can be a life-threatening infection in immunocompromised patients. The 2023 EULAR Vasculitis guidelines recommends primary prophylaxis with antibiotics, especially in rheumatic disease patients receiving rituximab (RTX).

National Population Insights (4.28.2023)

Save

Dr. Jack Cush reviews the news and journal reports and addresses 3 viewer case questions.

Romania to U.S.: My Journey to a Permanent Residency

Save

One in four practicing physicians in the United States are international medical graduates. I am one of them. Here is what I learned, and my advice to others who are on a similar journey.

25 Great Women in Rheumatology

Save

This week I reached out to many leaders in rheumatology and asked: who are the great women in rheumatology who should be recognized? This was prompted by a smart article in Annals of Rheumatic Disease written by Drs. Tuhina Neogi (Boston) and Nicola Dalbeth (N. Zealand), entitled "Where are the women ‘Heroes and Pillars of Rheumatology’?

Narrative Medicine

Save

I am a woman in pediatric rheumatology. Even in a predominantly female field, at times I feel compelled to mask my emotional response to the consistently complicated, often overwhelming and sometimes ambiguous nature of the job. Rather than detach, however, I choose to emotionally engage with the medical experience through my own medicine: narratives.

Denosumab Reduces Type II Diabetes Risk

Save

The British Medical Journal has publish a matched cohort analysis demonstrating that adults receiving denosumab had a lower risk of incident type 2 diabetes (NIDDM) compared with those taking oral bisphosphonates for osteoporosis.